Ascend Wellness Holdings (AAWH) Deferred Taxes (2020 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Deferred Taxes came in at -$2.4 million in Q1 2026, up 22.02% year-on-year from -$2.0 million in Q1 2025, and down 423.88% quarter-over-quarter from $737000.0 in Q4 2025.
Ascend Wellness Holdings (AAWH) Deferred Taxes (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Deferred Taxes history runs 7 years deep, the most recent figure standing at -$2.4 million for Q1 2026.
- On a quarterly basis, Deferred Taxes rose 22.02% year-over-year to -$2.4 million in Q1 2026; TTM through Mar 2026 was -$7.3 million, a 39.56% increase from a year earlier, with the FY2025 full-year figure at -$8.0 million, up 35.1% from the prior year.
- Deferred Taxes slipped to -$2.4 million in Q1 2026 per AAWH's latest filing, from $737000.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $737000.0 in Q4 2025 and bottomed at -$6.5 million in Q3 2023.
- The 5-year median for Deferred Taxes is -$2.2 million (2024), against an average of -$2.4 million.
- Across the five-year window, Deferred Taxes sank 306.64% in 2023 and soared 134.62% in 2025, its largest moves.
- Year by year, Deferred Taxes stood at -$2.0 million in 2022, then jumped by 32.27% to -$1.4 million in 2023, then tumbled by 54.84% to -$2.1 million in 2024, then jumped by 134.62% to $737000.0 in 2025, then sank by 423.88% to -$2.4 million in 2026.
- Per Business Quant, the three latest AAWH Deferred Taxes figures stand at -$2.4 million (Q1 2026), $737000.0 (Q4 2025), and -$3.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -22.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 34.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 25.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -69.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -61.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Ascend Wellness Holdings | 83.00 Mn | 22.91 Mn | 44.88 Mn | -2.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.39 Mn |
| Dec 31, 2025 | 737,000.00 |
| Sep 30, 2025 | -3.06 Mn |
| Jun 30, 2025 | -2.60 Mn |
| Mar 31, 2025 | -3.06 Mn |
| Dec 31, 2024 | -2.13 Mn |
| Sep 30, 2024 | -4.70 Mn |
| Jun 30, 2024 | -2.21 Mn |
| Mar 31, 2024 | -3.27 Mn |
| Dec 31, 2023 | -1.38 Mn |
| Sep 30, 2023 | -6.49 Mn |
| Jun 30, 2023 | -2.22 Mn |
| Mar 31, 2023 | -2.17 Mn |
| Dec 31, 2022 | -2.03 Mn |
| Sep 30, 2022 | -1.60 Mn |
| Jun 30, 2022 | -981,000.00 |
| Mar 31, 2022 | -1.15 Mn |
| Dec 31, 2021 | -1.75 Mn |
| Sep 30, 2021 | -833,000.00 |
| Jun 30, 2021 | -260,000.00 |